Vancomycin-Resistant Enterococci in Brooklyn, New York: A Moment in Time
Vancomycin-resistant enterococci (VRE) have rapidly spread throughout hospitals in the United States and, once introduced into hospitals, have been difficult to eradicate. To determine the citywide epidemiology and antibiotic susceptibility of enterococci, we collected all enterococcal isolates from 15 hospitals in Brooklyn, New York, in November 1997.
The average daily census and the average length of hospitalization for the month of November 1997 were obtained from each hospital. To estimate the prevalence of VRE at each hospital, the number of positive cultures per 1000 patient-days was determined. Data on the use of antibiotics were requested from the participating hospitals. Whenever possible, antibiotic usage data for the month of November 1997 were obtained (7 hospitals); if this information was not available, data on antibiotic purchases were obtained (3 hospitals). The number of units of each class of antibiotic (penicillins, cephalosporins, carbapenems, quinolones, aminoglycosides, vancomycin, metronidazole, and clindamycin) was divided by the total number of antibiotic units, and the relative use of each class of antibiotic was then compared between hospitals. Univariate and multivariate linear regression analyses were employed to determine any relationship between the prevalence of VRE with the average length of hospitalization and the percentages of each class of antibiotic for each hospital. Isolates that were found to be resistant to vancomycin were further examined by use of contour-clamp homogeneous electric field electrophoresis [1] and analyzed by means of recommended definitions [2] .
A total of 516 enterococcal isolates were collected. Enterococcus faecalis accounted for 430 (83%) of the isolates, and Enterococcus faecium, for 69 (13%) of the isolates. Overall, 18% of the enterococci were resistant to vancomycin; 13 of the 15 hospitals submitted at least one resistant isolate. Vancomycin resistance was found in 61 (88%) of 69 E. faecium isolates and 26 (6%) of 430 E. faecalis isolates. Results of antibiotic susceptibility testing for the vancomycin-resistant isolates are reported in table 1.
E. faecium accounted for 67% of the vancomycin-resistant isolates, and these isolates were highly resistant (MIC, у64 mg/ mL) to vancomycin. The vancomycin-resistant isolates were less likely to be susceptible to gentamicin (10% vs. 88%, respectively;
) and trovafloxacin (10% vs. 62%, respectively; P ! .001 P = ) than were vancomycin-susceptible E. faecium isolates. .001 There was no difference in the rates of susceptibility to doxycycline between the 2 groups. Univariate regression analysis of antibiotic usage data (available from 10 hospitals) revealed a significant association between the prevalence of vancomycinresistant E. faecium and both clindamycin usage ( ) and P = .04 greater average length of hospitalization ( ). In the mul-P ! .02 tivariate analysis, only greater average length of hospitalization was significantly associated with the prevalence. A total of 33 unique strains, including 9 clusters, were identified among the 61 resistant isolates; 2 clusters, accounting for 18% and 10% of the isolates, were each recovered from 4 different hospitals. There was both a considerable amount of sharing of isolates between hospitals and a heterogeneity of strains from individual hospitals.
Of the 91 VRE identified in this survey, 26 (29%) were identified as E. faecalis. Most (69%) of these isolates had a low level of resistance to vancomycin (MIC, 16-32 mg/mL). Vancomycin-resistant E. faecalis isolates were less likely to be sus- CID 1999; 29 (December) ceptible to gentamicin (12% vs. 71%, respectively;
) and P ! .001 trovafloxacin (0% vs. 58%, respectively; ) than were P ! .001 vancomycin-susceptible E. faecalis isolates. Univariate regression analysis revealed a significant association between the prevalence of vancomycin-resistant E. faecalis and usage of quinolones ( ), but this association became a trend in the P = .05 multivariate analysis ( ). Pulsed-field gel electrophoresis P = .067 revealed 9 unique strains, including 5 clusters, among the 26 vancomycin-resistant E. faecalis isolates. One-half of the isolates, recovered from 7 different hospitals, belonged to 1 cluster. There was no obvious difference between the antibiotic susceptibility profile of this cluster and those of the other clusters of vancomycin-resistant E. faecalis; the remaining clusters were small numbers of isolates generally recovered from 1 or 2 hospitals.
Although the intrahospital epidemiology and spread of vancomycin-resistant E. faecium have been well chronicled, there is a relative paucity of data detailing their interhospital transmission. The interhospital spread of distinct strains has been documented in Detroit [3] , San Antonio [4] , and Michigan state [5] . We found an extremely heterogeneous population of vancomycin-resistant E. faecium without the clear predominance of 1 strain. The rapid spread of vancomycin resistance to such a diverse population of enterococci suggests the presence of mobile genetic material (e.g., transposons).
E. faecalis usually accounts for only a small number of vancomycin-resistant isolates. In this report, 6% of E. faecalis isolates were resistant to vancomycin. However, 29% of vancomycin-resistant isolates were E. faecalis. Although all of these isolates were susceptible to ampicillin, most had acquired resistance to gentamicin and quinolones. Higher prevalences were reported in hospitals that used a proportionally greater amount of quinolones. One consequence of the expanding role of quinolones in the treatment of community-acquired and nosocomial infections may be the emergence of quinolone-resistant E. faecalis. One strain accounted for 50% of the vancomycin-resistant E. faecalis isolates and was detected in 7 of the 15 hospitals. The reason why this strain predominated is not clear, since the antibiotic resistance profile was similar to those of the other less frequent strains.
It is not evident precisely how strains of E. faecium and E. faecalis are transmitted between hospitals. Patients with prolonged gastrointestinal colonization may be admitted to11 hospital and introduce the pathogen at each medical center. In addition, patients colonized with similar strains may originate from a common facility (e.g., a nursing home) and be transferred to different hospitals. Finally, health care workers may work at 11 hospital and carry a pathogen to the facilities. Given the widespread nature of the problem in Brooklyn, it is likely that a global approach involving surveillance and coordinated antibiotic controls at all health care centers in the region will be needed to control the spread of vancomycin resistance. 
